These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27330133)

  • 1. Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
    Maiorino MI; Bellastella G; Giugliano D; Esposito K
    Diabetes Care; 2016 Jul; 39(7):e102-3. PubMed ID: 27330133
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Mita et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
    Mita T; Katakami N; Shimomura I; Watada H
    Diabetes Care; 2016 Jul; 39(7):e104-5. PubMed ID: 27330134
    [No Abstract]   [Full Text] [Related]  

  • 3. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H;
    Diabetes Care; 2016 Mar; 39(3):455-64. PubMed ID: 26822324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H;
    Diabetes Care; 2017 Jun; 40(6):808. PubMed ID: 28420697
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).
    Katakami N; Mita T; Irie Y; Takahara M; Matsuoka TA; Gosho M; Watada H; Shimomura I;
    Cardiovasc Diabetol; 2018 Feb; 17(1):24. PubMed ID: 29402270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Gosho M; Shimomura I; Watada H;
    J Diabetes Investig; 2017 Mar; 8(2):254-255. PubMed ID: 28256102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Gosho M; Shimomura I; Watada H
    Int J Endocrinol; 2017; 2017():1925305. PubMed ID: 28250768
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H
    Diabetol Metab Syndr; 2014 Mar; 6(1):35. PubMed ID: 24607023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitagliptin on Carotid Intima-Media Thickness in Type 2 Diabetes Mellitus Patients and Anemia: A Subgroup Analysis of the PROLOGUE Study.
    Lu Z; Ma G; Chen L
    Mediators Inflamm; 2020; 2020():8143835. PubMed ID: 32454794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus.
    Ishikawa S; Shimano M; Watarai M; Koyasu M; Uchikawa T; Ishii H; Inden Y; Takemoto K; Murohara T
    Am J Cardiol; 2014 Aug; 114(3):384-8. PubMed ID: 24929624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.
    Mita T; Katakami N; Shiraiwa T; Yoshii H; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Gosho M; Shimomura I; Watada H
    Sci Rep; 2017 Jan; 7():39965. PubMed ID: 28067320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents and young adults with newly diagnosed Type 2 diabetes demonstrate greater carotid intima-media thickness than those with Type 1 diabetes.
    Gu W; Huang Y; Zhang Y; Hong J; Liu Y; Zhan W; Ning G; Wang W
    Diabet Med; 2014 Jan; 31(1):84-91. PubMed ID: 24112039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study.
    Zhao Y; Wang H; Ke D; Deng W; Ji Y; Yang J; Lin Z; Li G; Xiao L; Tang J; Chen Q
    Ther Adv Chronic Dis; 2021; 12():20406223211026993. PubMed ID: 34221308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid Intima-Media Thickness, Ankle-Arm Index, and Inflammation Profile in Mexican Patients with Early and Late Onset Type 2 Diabetes.
    Contreras-Rodríguez A; Gómez-Díaz RA; Tanus-Hajj J; Talavera JO; Mondragón-González R; Wacher NH
    Rev Invest Clin; 2015; 67(4):240-9. PubMed ID: 26426590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating annexin A5 levels are associated with carotid intima-media thickness but not coronary plaque composition.
    Burgmaier M; Reith S; Schurgers L; Kahles F; Marx N; Reutelingsperger C
    Diab Vasc Dis Res; 2017 Sep; 14(5):415-422. PubMed ID: 28592134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of comprehensive intensive therapies on the change of intima-media thickness of carotid arteries in type 2 diabetic patients: A report of 4-year follow-up with a literature review.
    Cheng LJ; Xu ZR; Zhang Q; Wang ZD; Wu FW; Yang WX
    Diab Vasc Dis Res; 2016 Jan; 13(1):31-40. PubMed ID: 26499916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family histories of Type II diabetes and hypertension predict intima-media thickness in patients with Type I diabetes.
    Mäkimattila S; Ylitalo K; Schlenzka A; Taskinen MR; Summanen P; Syvänne M; Yki-Järvinen H
    Diabetologia; 2002 May; 45(5):711-8. PubMed ID: 12107752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha-glucosidase inhibitors on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Geng DF; Jin DM; Wu W; Fang C; Wang JF
    Atherosclerosis; 2011 Sep; 218(1):214-9. PubMed ID: 21640349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.
    Mudríková T; Szabová E; Tkác I
    Wien Klin Wochenschr; 2000 Oct; 112(20):887-91. PubMed ID: 11244615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.